Accuracy of the Accuro 3S

计划入组 50 人 · 首次发布于 2026 年 3 月 9 日

Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1

计划入组 15 人 · 首次发布于 2015 年 3 月 17 日

Preventing Tobacco Relapse With Omega-3s Trial

首次发布于 2017 年 4 月 13 日

NeuLiv

Filgrastim biosimilar(Bio Genomics, Inc.)

VB1-008(Sesen Bio, Inc.)

3S-Pharmacological Consultation & Research GmbH

Germany

Belite Bio, Inc.

United States

DAEWOONG BIO INC.

South Korea

Sunshine Guojian Posts 95% Profit Surge as Two Autoimmune Antibodies Win NMPA Approval

FDA Authorizes AI Algorithm Updates for Beacon Biosignals' Dreem 3S Sleep Wearable

Omega-3 Supplementation and Cardiovascular Health: Mixed Results and Nuanced Benefits